Skip to main content

Table 1 Clinicopathologic information of the cervical cancer patients

From: Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response

Feature

Total (%)

Number

307 (100)

Age

 ≤ 50 years

188 (61.2)

 > 50 years

119 (38.8)

Histological type

 Squamous cell carcinoma

254 (82.7)

 Endocervical adenocarcinoma

47 (15.3)

 Adenosquamous carcinoma

6 (2.0)

Vital status

 Alive

235 (76.5)

 Dead

72 (23.5)

Postoperative Treatment

 Yes

103 (33.6)

 No

77 (25.1)

Clinical stage

 I

163 (53.1)

 II

70 (22.8)

 III

46 (15.0)

 IV

21 (6.8)

Morphological type

 Non-keratininzing type

120 (39.1)

 Keratininzing type

55 (17.9)

Lymphatic invasion

 Absent

72 (23.5)

 Present

80 26.1)

Human papilloma virus status

 Negative

23 (7.5)

 Positive (High risk)

284 (92.5)

 Hpv 16

172 (56.0)

 Hpv 18

39 (12.7)

 Hpv 45

24 (7.8)

 Hpv etc

47 (15.3)